Long-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension

Article

Abstract: Objective: To investigate the long-term efficacy and tolerability of osilodrostat, a potent oral 11β

Palabras claves:

Autores:

Belaya Z., Biller B.M.K., Feelders R.A., Fleseriu M., Houde G., Izquierdo M., Newell-Price J., Pedroncelli A.M., Pivonello R., Richard J. Auchus, Roughton M., Scaroni C., Shimatsu A., Vila G., Walia R.

Fuentes:

scopus